Cargando…

Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era

Detalles Bibliográficos
Autores principales:	Qin, Wei, Dong, Fen, Zhang, Zhu, Hu, Bingzhu, Chen, Shi, Zhu, Ziyang, Li, Fajiu, Wang, Xiaojiang, Zhang, Yunxia, Wang, Yimin, Zhen, Kaiyuan, Wang, Jing, Elalamy, Ismaïl, Li, Chenghong, Zhai, Zhenguo, Davidson, Bruce L., Wang, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681071/ https://www.ncbi.nlm.nih.gov/pubmed/33249247 http://dx.doi.org/10.1016/j.thromres.2020.11.020

Ejemplares similares

Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up
por: Qin, Wei, et al.
Publicado: (2021)

Awareness and Prophylaxis of Venous Thromboembolism in Patients with COVID-19: A National Cross-Sectional Survey in Epidemic Era
por: Zhang, Zhu, et al.
Publicado: (2020)

Interlocking detachable coil embolization for giant tandem bronchial aneurysms: A case report
por: Chen, Yingjie, et al.
Publicado: (2021)

The earlier, the better? A review of neoadjuvant immunotherapy in resectable non‐small‐cell lung cancer
por: Li, Fajiu, et al.
Publicado: (2022)

Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
por: Preti, Paola S., et al.
Publicado: (2021)

Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020)

Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group
por: Ray, Joel G., et al.
Publicado: (2021)

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
por: Moll, Matthew, et al.
Publicado: (2021)

Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
por: Lawlor, Matthew, et al.
Publicado: (2021)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

72-year-old woman with dyspnoea and pulmonary artery filling defects on CT angiogram
por: Qin, Wei, et al.
Publicado: (2022)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study
Publicado: (2021)

The miR‐124‐3p regulates the allergic airway inflammation and remodeling in an ovalbumin‐asthmatic mouse model by inhibiting S100A4
por: Liu, Min, et al.
Publicado: (2023)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2020)

Azithromycin effectively inhibits tumor angiogenesis by suppressing vascular endothelial growth factor receptor 2-mediated signaling pathways in lung cancer
por: Li, Fajiu, et al.
Publicado: (2017)

In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist
por: Wang, Lan, et al.
Publicado: (2020)

Non-Ischemic, Non-Hypoxic Myocardial Injury, and Long-Term Mortality in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study
por: Li, Fajiu, et al.
Publicado: (2022)

The Ribosomal Protein L28 Gene Induces Sorafenib Resistance in Hepatocellular Carcinoma
por: Shi, Yi, et al.
Publicado: (2021)

Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia()
por: Huang, Ching-Tai, et al.
Publicado: (2021)

High mobility group box 1 (HMGB 1): a new protein in the pathogenesis of ENT inflammatory and infectious diseases
por: PASSALI, D., et al.
Publicado: (2012)

Effect on thromboprophylaxis among hospitalized patients using a system-wide multifaceted quality improvement intervention: Rationale and design for a multicenter cluster randomized clinical trial in China
por: Dong, Fen, et al.
Publicado: (2020)

Higher Incidence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism in Asians Than in Europeans: A Meta-Analysis
por: Pang, Wenyi, et al.
Publicado: (2021)

Circulating biomarkers in chronic thromboembolic pulmonary hypertension
por: Zhang, Meng, et al.
Publicado: (2019)

Running Away to the Circus
por: Wilcox, Lynne S.
Publicado: (2007)

Healthy Behavior: The Truth
por: Wilcox, Lynne S.
Publicado: (2008)

Matters of the Heart
por: Wilcox, Lynne S.
Publicado: (2008)

Fresh Perspectives
por: Wilcox, Lynne S.
Publicado: (2008)

Grandmother Spider: Connecting All Things
por: Wilcox, Lynne S.
Publicado: (2006)

Revolution
por: Wilcox, Lynne S.
Publicado: (2004)

Measuring the Dash
por: Wilcox, Lynne S.
Publicado: (2005)

Summertime
por: Wilcox, Lynne S.
Publicado: (2004)

Peas and Primroses
por: Wilcox, Lynne S.
Publicado: (2005)

Extending Our Reach
por: Wilcox, Lynne S.
Publicado: (2004)

It Constitutes Itself: Health and Community
por: Wilcox, Lynne S.
Publicado: (2006)

Kitchen Girl
por: Wilcox, Lynne S.
Publicado: (2006)

A Cold Black Humour
por: Wilcox, Lynne S.
Publicado: (2006)

Health Monitoring and Life on the Mississippi
por: Wilcox, Lynne S.
Publicado: (2004)

This World Is Yours
por: Wilcox, Lynne S.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_kf2gv068fcdfhrlq46bfm7lepm